Sign up
Log in
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Share
Listen to the news

Gainers

  • Eyenovia (NASDAQ:EYEN) shares moved upwards by 56.6% to $1.77 during Tuesday's pre-market session. The market value of their outstanding shares is at $5.0 million. The company's, Q1 earnings came out yesterday.
  • Instil Bio (NASDAQ:TIL) shares increased by 30.17% to $22.0. The company's market cap stands at $144.3 million.
  • Healthcare Triangle (NASDAQ:HCTI) stock increased by 27.47% to $0.01.
  • Iridex (NASDAQ:IRIX) stock moved upwards by 25.23% to $1.34. The market value of their outstanding shares is at $22.2 million.
  • bioAffinity Technologies (NASDAQ:BIAF) stock rose 24.84% to $0.28. The market value of their outstanding shares is at $5.1 million. The company's, Q1 earnings came out 3 days ago.
  • Regencell Bioscience (NASDAQ:RGC) stock increased by 14.48% to $403.0. The company's market cap stands at $5.2 billion.

Losers

  • Protagenic Therapeutics (NASDAQ:PTIX) stock fell 20.7% to $8.8 during Tuesday's pre-market session. The market value of their outstanding shares is at $5.1 million.
  • Entero Therapeutics (NASDAQ:ENTO) shares fell 19.6% to $0.33. The company's market cap stands at $1.5 million. As per the news, the Q1 earnings report came out 3 days ago.
  • Ekso Bionics Holdings (NASDAQ:EKSO) stock decreased by 18.16% to $0.27. The company's market cap stands at $7.8 million.
  • Lyra Therapeutics (NASDAQ:LYRA) stock decreased by 13.1% to $0.09. The company's market cap stands at $6.1 million.
  • Brainstorm Cell (NASDAQ:BCLI) stock decreased by 11.03% to $1.21. The company's market cap stands at $6.9 million. The company's, Q1 earnings came out 3 days ago.
  • Plus Therapeutics (NASDAQ:PSTV) stock declined by 10.45% to $0.3. The market value of their outstanding shares is at $1.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.